covid 19 News and Research

RSS

Study uses novel statistical approaches to identify factors that contributed to COVID-19 mortality

Staying home and limiting local travel, supporting access to primary care, and limiting contacts in contagion hubs - including hospitals, schools, and workplaces - are strategies that might help reduce COVID-19-related deaths, according to new research. The research team, by statisticians at Penn State, the Sant'Anna School of Advanced Studies in Pisa, Italy, and Université Laval in Quebec, Canada, used novel statistical approaches to compare the first wave of the epidemic across 20 regions in Italy and identify factors that contributed to mortality.

31 Aug 2021

Durability of cellular immune memory to SARS-CoV-2 after mRNA vaccination

A recent study, available on the bioRxiv* preprint server, investigated the durability of cellular immune memory after mRNA vaccination against SARS-CoV-2 and whether booster jabs affect the durability of different immune response components. The study included testing for antibodies and cellular immune responses in covid patients and recovered individuals.

31 Aug 2021

Science advisors gather in an international call for evidence-based policy making

The largest-ever independent gathering of interest groups, thought-leaders, science advisors to governments and global institutions, researchers, academics, communicators and diplomats is taking place in Montreal and online.

31 Aug 2021

SARS-CoV-2 animal origin: What we know so far

Scientists at the University of Glasgow Centre for Virus Research in the United Kingdom and the South China Agricultural University in Guangzhou, China, have shed light on the animal origin of SARS-CoV-2, tracing back to the first outbreak of the severe acute respiratory syndrome coronavirus (SARS-CoV), the infectious agent of the severe acute respiratory syndrome (SARS) in China in 2002 to 2003.

31 Aug 2021

New evidence provides strong support for the halt on prescribing hydroxychloroquine for COVID-19

In 2021, in the United States alone, there have been more than 560,000 prescriptions of hydroxychloroquine for the prevention, post-exposure and treatment of COVID-19.

31 Aug 2021

Monoclonal antibody treatment combo can reduce the impact of COVID-19 in high-risk patients

In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab - two monoclonal antibody treatments under Food and Drug Administration emergency use authorization - keep high-risk patients out of the hospital when infected with mild to moderate COVID-19. The findings appear in The Lancet's EClinicalMedicine.

31 Aug 2021

Scientists identify potential biomarkers to predict COVID-19 outcomes

A team of scientists from the United States has recently examined the trajectory of early immune biomarkers in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. They have identified specific plasma proteins that can accurately predict the clinical and virological outcomes in SARS-CoV-2 infected patients. The study is currently available on the medRxiv* preprint server.

31 Aug 2021

Vaccinated individuals with breakthrough SARS-CoV-2 infection have much lower risk of hospitalization

A recent study conducted by a team of US-based scientists has revealed that unvaccinated individuals are 17-times more likely to be hospitalized due to severe coronavirus disease 2019 (COVID-19) compared to those vaccinated against the disease. The study is currently available on the medRxiv* preprint server.

31 Aug 2021

University of Kentucky Center for Clinical and Translational Science receives $23.5 million NIH award

The University of Kentucky Center for Clinical and Translational Science has received a $23.5 million, four-year award from the National Center for Advancing Translational Sciences at the National Institutes of Health.

30 Aug 2021

Researchers identify 55 lingering effects of COVID-19

As COVID-19 hospitalizations once again soar in a fourth surge more than 18 months after the pandemic started, some patients continue to experience symptoms long after recovering from COVID, according to a Houston Methodist study recently published in Nature's Scientific Reports.

30 Aug 2021

COVID-19 vaccine elicits antibody responses in nearly 9 out of 10 people taking immunosuppressants

COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.

30 Aug 2021

Computational study identifies human proteins structurally similar to SARS-CoV-2 proteins

A new study published in Scientific Reports identifies the human proteins that share structural similarities with the SARS-CoV-2 proteins.

30 Aug 2021

Researchers urge neurologists to actively encourage vaccinations for Parkinson's patients

Patients with Parkinson's disease (PD) are at higher risk for vaccine-preventable respiratory illnesses. However, patients with advanced PD may have less access to vaccinations according to a new study published in the Journal of Parkinson's Disease.

30 Aug 2021

Influenza vaccination should become a part of standard hospital care after myocardial infarction

Influenza vaccination reduces the risk of all-cause death, myocardial infarction, or stent thrombosis at 12 months in hospitalized patients with myocardial infarction or high-risk coronary disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2021.

30 Aug 2021

covid 19 News and Research

Study uses novel statistical approaches to identify factors that contributed to COVID-19 mortality

Durability of cellular immune memory to SARS-CoV-2 after mRNA vaccination

Science advisors gather in an international call for evidence-based policy making

SARS-CoV-2 animal origin: What we know so far

New evidence provides strong support for the halt on prescribing hydroxychloroquine for COVID-19

Monoclonal antibody treatment combo can reduce the impact of COVID-19 in high-risk patients

Scientists identify potential biomarkers to predict COVID-19 outcomes

Vaccinated individuals with breakthrough SARS-CoV-2 infection have much lower risk of hospitalization

University of Kentucky Center for Clinical and Translational Science receives $23.5 million NIH award

Researchers identify 55 lingering effects of COVID-19

COVID-19 vaccine elicits antibody responses in nearly 9 out of 10 people taking immunosuppressants

Computational study identifies human proteins structurally similar to SARS-CoV-2 proteins

Researchers urge neurologists to actively encourage vaccinations for Parkinson's patients

Influenza vaccination should become a part of standard hospital care after myocardial infarction

How early interferon curbs SARS-CoV-2 infection

Prevalence of vaccine breakthrough cases in SF Bay Area

Researchers study the role of low-density granulocytes in COVID-19

Will mRNA vaccine boosters be required for SARS-CoV-2 variants?

Sustained and effective response to Janssen COVID-19 vaccine Is enhanced by delayed booster

Can SARS-CoV-2 be transmitted in the food cold chain?

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News